Skip to content
Forskning· LaunchAvailable

Google DeepMind launches AlphaGenome for genome sequence analysis

Google DeepMind has launched AlphaGenome, a model designed to analyse the human genome and predict how genetic variations affect biological mechanisms.

By the Aheadline editorial team·8 juli 2026·2 min read·Source: Entity-watch: Google DeepMindAggregerad källaAI-generated
Google DeepMind launches AlphaGenome for genome sequence analysis
Google DeepMind launches AlphaGenome for genome sequence analysis
Google DeepMind launches AlphaGenome for genome sequence analysis
By · Verktygs- & infrastrukturreporter
Last updated

What happened?

Google DeepMind has developed and launched AlphaGenome, an advanced deep learning model. AlphaGenome is designed to decipher the functional regulatory code of the human genome. It processes large DNA sequences, up to one million base pairs, at single-base resolution to predict the impact of genetic variations on molecular and biological processes.

Key facts

UtvecklareGoogle DeepMind
FunktionDechiffrera funktionell regleringskod i mänskligt genom
AnalyskapacitetUpp till 1 miljon baspar DNA
UpplösningEnskild bas
PlattformGemini Enterprise Agent Platform, Google Cloud
HårdvarukravNVIDIA A100 eller H100 GPU:er

AlphaGenome is a state-of-the-art deep learning model developed by Google DeepMind. It is designed to decipher the functional regulatory code of the human genome.

Google Cloud Documentation · Google Cloud Documentation

By analyzing large-scale DNA sequences (up to 1 million base pairs) at single-base resolution, the model predicts how genetic variations affect molecular and biological mechanisms such as gene expression, chromatin accessibility, and RNA splicing.

Google Cloud Documentation · Google Cloud Documentation

AlphaGenome requires a minimum of one node and can be deployed to Agent Platform endpoints using specific machine types equipped with NVIDIA A100 or H100 accelerators.

Google Cloud Documentation · Google Cloud Documentation

Why it matters

The model is critical for understanding how genetic variations influence gene expression, chromatin accessibility, and RNA splicing. This could lead to new insights in genetics and medicine by enabling detailed analysis of complex genomic data.

Who is affected?

Researchers and developers in genetics, bioinformatics, and medicine are directly affected. Companies using Google Cloud Platform and the Gemini Enterprise Agent Platform can implement the model. Indirectly, patients and the healthcare sector may benefit from an improved understanding of the genetic basis of diseases.

Impact on the EU

AlphaGenome is available globally via Google Cloud Platform. The model can be used by EU-based organisations that meet the hardware and infrastructure requirements. No specific EU status relevance.

What else you should know

The documentation describes the process for deploying and using AlphaGenome, including details regarding hardware and usage requirements. A video about the model is 30 minutes long.

Frequently asked questions

Quick answers about this story

Vad har hänt?
Google DeepMind har lanserat AlphaGenome, en djupinlärningsmodell för att analysera det mänskliga genomet och förutsäga hur genetiska variationer påverkar biologiska mekanismer.
När hände det?
Modellen har officiellt lanserats och är nu tillgänglig. Lanseringsdatumet 25 mars 2024 baseras på den officiella dokumentationens publiceringsdatum.
Varför spelar det roll?
AlphaGenome möjliggör en djupare förståelse för hur genetiska variationer påverkar genuttryck, kromatintillgänglighet och RNA-splitsning, vilket har potential att revolutionera genetik och medicin.
Vilka hårdvarukrav finns?
AlphaGenome kräver specifika maskintyper med NVIDIA A100 eller H100 acceleratorer för optimal prestanda och skalbarhet på Google Cloud Platform.
Original source
Entity-watch: Google DeepMind·docs.cloud.google.com

The link opens in a new window and leads to the publisher's own site.

Aggregerad källa

Källan är en aggregator eller syndikering — vi rekommenderar att verifiera hos primärutgivaren.

AI-verktyg i artikeln

Topics

#Agents#Models
[ STAY UP TO DATE ]

Get similar news straight to your inbox

No affiliate linksCancel anytimeGDPR-friendly
[ Frequency ]
[ What do you want to read about? ]

You'll receive updates on 2 topics.

The reader's room

Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.

Sign in to submit a comment or question.

Loading comments…
How this affects you

Read the article through your role

  • Decide whether this affects strategy over 6–12 months or is just noise.
  • Discuss with leadership: do we own the right question or does ownership need to move?
  • Ask: what risk are we taking by NOT acting on this this quarter?

Generated angle — not editorial analysis of "Google DeepMind launches AlphaGenome for genome sequence ana"